These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18391980)

  • 1. Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.
    Perotti D; Gamba B; Sardella M; Spreafico F; Terenziani M; Collini P; Pession A; Nantron M; Fossati-Bellani F; Radice P
    Oncogene; 2008 Jul; 27(33):4625-32. PubMed ID: 18391980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumor with an apparently balanced translocation t(X;18) resulting in deletion of the WTX gene.
    Han M; Rivera MN; Batten JM; Haber DA; Dal Cin P; Iafrate AJ
    Genes Chromosomes Cancer; 2007 Oct; 46(10):909-13. PubMed ID: 17620295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor.
    Rivera MN; Kim WJ; Wells J; Driscoll DR; Brannigan BW; Han M; Kim JC; Feinberg AP; Gerald WL; Vargas SO; Chin L; Iafrate AJ; Bell DW; Haber DA
    Science; 2007 Feb; 315(5812):642-5. PubMed ID: 17204608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.
    Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L
    Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.
    Ruteshouser EC; Robinson SM; Huff V
    Genes Chromosomes Cancer; 2008 Jun; 47(6):461-70. PubMed ID: 18311776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.
    Wegert J; Wittmann S; Leuschner I; Geissinger E; Graf N; Gessler M
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1102-11. PubMed ID: 19760609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine inhibits Wilms' tumor cell progression through upregulation of Wilms' tumor gene on the X chromosome.
    Liu Y; Liu S
    Mol Med Rep; 2013 Nov; 8(5):1537-41. PubMed ID: 24002362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilms tumor genetics: a new, UnX-pected twist to the story.
    Huff V
    Cancer Cell; 2007 Feb; 11(2):105-7. PubMed ID: 17292822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of WTX gene in Wnt/ beta-catenin pathway in gastric, colorectal, and hepatocellular carcinomas.
    Yoo NJ; Kim S; Lee SH
    Dig Dis Sci; 2009 May; 54(5):1011-4. PubMed ID: 18720004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein.
    Camp ND; James RG; Dawson DW; Yan F; Davison JM; Houck SA; Tang X; Zheng N; Major MB; Moon RT
    J Biol Chem; 2012 Feb; 287(9):6539-50. PubMed ID: 22215675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.
    Akhavanfard S; Vargas SO; Han M; Nitta M; Chang CB; Le LP; Fazlollahi L; Nguyen Q; Ma Y; Cosper A; Dias-Santagata D; Han JY; Bergethon K; Borger DR; Ellisen LW; Pomeroy SL; Haber DA; Iafrate AJ; Rivera MN
    Genes Chromosomes Cancer; 2014 Jan; 53(1):67-77. PubMed ID: 24249259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of Wilms tumor-suppressor WTX and tumor-associated mutants.
    Kim MK; Min DJ; Rabin M; Licht JD
    Oncogene; 2011 Feb; 30(7):832-42. PubMed ID: 20956941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The General Expression Analysis of WTX Gene in Normal and Cancer Tissues.
    Zhang YY; Wang QM; Niu HL; Liu X; Zhang QL
    Pathol Oncol Res; 2017 Apr; 23(2):439-446. PubMed ID: 28032309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WTX mutations can occur both early and late in the pathogenesis of Wilms tumour.
    Fukuzawa R; Holman SK; Chow CW; Savarirayan R; Reeve AE; Robertson SP
    J Med Genet; 2010 Nov; 47(11):791-4. PubMed ID: 20679664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, Pathologic, and Genetic Features of Wilms Tumors With WTX Gene Mutation.
    Alexandrescu S; Akhavanfard S; Harris MH; Vargas SO
    Pediatr Dev Pathol; 2017; 20(2):105-111. PubMed ID: 28326956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
    Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR
    Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canonical WNT signalling determines lineage specificity in Wilms tumour.
    Fukuzawa R; Anaka MR; Weeks RJ; Morison IM; Reeve AE
    Oncogene; 2009 Feb; 28(8):1063-75. PubMed ID: 19137020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562.
    Drake KM; Ruteshouser EC; Natrajan R; Harbor P; Wegert J; Gessler M; Pritchard-Jones K; Grundy P; Dome J; Huff V; Jones C; Aldred MA
    Clin Cancer Res; 2009 Oct; 15(19):5985-92. PubMed ID: 19789318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is predisposition for nephroblastoma linked to polymorphisms of the WTX gene?
    Guertl B; Leuschner I; Guelly C; Ebner B; Kronberger C; Hoefler G
    Pathol Oncol Res; 2010 Jun; 16(2):189-91. PubMed ID: 19757195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases.
    Safford SD; Goyeau D; Freemerman AJ; Bentley R; Everett ML; Grundy PE; Skinner MA
    Ann Surg Oncol; 2003 Mar; 10(2):136-43. PubMed ID: 12620908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.